Purdue

Purdue Pharma, along with its controlling Sackler family, has recently hammered out a staggering $7.4 billion agreement aimed at settling a tidal wave of lawsuits. These cases allege that the painkiller OxyContin played a significant role in igniting the opioid addiction catastrophe gripping the United States, as affirmed by several state attorneys general. This settlement comes nearly seven months after the U.S. Supreme Court upended Purdue’s earlier bid for resolution via a bankruptcy settlement. At that time, Purdue…